QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kennedy, J. C. Articles by Wells, P. G. Search for Related Content PubMed PubMed Citation Articles by Kennedy, J. C. Articles by Wells, P. G.

Antisense Evidence for Nuclear Factor-B–Dependent Embryopathies Initiated by Phenytoin-Enhanced Oxidative Stress

Faculty of Pharmacy (J.C.K., P.G.W.) and Department of Pharmacology (P.G.W.), University of Toronto, Toronto, Ontario, Canada; and Unite de Biologie Moleculaire de l'Expression Genique, Unité de Recherche Associée 2582 Centre National de la Recherche Scientifique, Institut Pasteur, Paris, France (S.M.)

Endogenous and xenobiotic-enhanced oxidative stress may initiate embryonic death and birth defects via reactive oxygen species (ROS) signaling pathways involving nuclear transcription factor-B (NF-B). Using embryo culture and a transgenic mouse engineered with a NF-B–dependent -galactosidase reporter gene, we employed NF-B antisense oligonucleotide therapy to determine whether NF-B signaling contributes to the embryopathic effects of the ROS-initiating teratogen phenytoin. Phenytoin selectively increased NF-B activity in target tissues and caused embryopathies, both of which were blocked by NF-B antisense oligonucleotides but not by sense and nonsense oligonucleotide controls. NF-B signaling may therefore contribute to the mechanism of ROS-mediated embryopathies.

Address correspondence to: Peter G. Wells, Faculty of Pharmacy, University of Toronto, 19 Russell St., Toronto, Ontario, Canada M5S 2S2. E-mail: pg.wells{at}utoronto.ca

This article has been cited by other articles:

				O. Pekar, N. Molotski, S. Savion, A. Fein, V. Toder, and A. Torchinsky p53 regulates cyclophosphamide teratogenesis by controlling caspases 3, 8, 9 activation and NF-{kappa}B DNA binding Reproduction, August 1, 2007; 134(2): 379 - 388. [Abstract] [Full Text] [PDF]

				Y. Bhuller, W. Jeng, and P. G. Wells Variable In Vivo Embryoprotective Role for Ataxia-Telangiectasia-Mutated against Constitutive and Phenytoin-Enhanced Oxidative Stress in Atm Knockout Mice Toxicol. Sci., September 1, 2006; 93(1): 146 - 155. [Abstract] [Full Text] [PDF]

				Y. Bhuller and P. G. Wells A Developmental Role for Ataxia-Telangiectasia Mutated in Protecting the Embryo from Spontaneous and Phenytoin-Enhanced Embryopathies in Culture Toxicol. Sci., September 1, 2006; 93(1): 156 - 163. [Abstract] [Full Text] [PDF]

				J. Yan and B. F. Hales Activator Protein-1 (AP-1) DNA Binding Activity Is Induced by Hydroxyurea in Organogenesis Stage Mouse Embryos Toxicol. Sci., June 1, 2005; 85(2): 1013 - 1023. [Abstract] [Full Text] [PDF]